Ramesh K. Ramanathan, MD, medical director, Clinical Trials Program, Virginia G. Piper Cancer Center, discusses the potential of identifying actionable targets in appendiceal cancers.

Andreana N. Holowatyj, PhD, MS, Assistant Professor of Medicine and Cancer Biology, Vanderbilt University Medical Center presented "Appendix Cancer in Young Adults: A Distinct Disease Burden" via Zoom on February 17, 2021.

As the incidence of appendiceal cancer continues to rise with causes unknown, little is currently known about the risk factors and etiologies of this rare malignancy—particularly among young individuals. This webinar will focus on our current knowledge of the unique appendix cancer burden among individuals younger than age 50 years at diagnosis (early-onset appendix cancer), including: demographic and clinical patterns, molecular features, and health disparities; and will also highlight future directions aimed at clinical implications for appendiceal cancer prevention, detection and treatment.

The objectives of this webinar were to:
(1) summarize current literature on the distinct burden of appendix cancer among young patients;
(2) understand the context of health disparities within the early-onset appendix cancer po****tion; and
(3) broaden knowledge in early-onset appendix cancer and ongoing research.

Oliver Eng, MD, Surgical Oncology at U of Chicago Cancer Center presents "Iterative HIPEC, Laparoscopic HIPEC, and Changes in PDL-1 Expression" at the Appendix Cancer Survivorship Symposium. This event was held virtually via Zoom on October 2, 2020.

Dr. Grotz, Surgical Oncologist from the Mayo Clinic presented: Mucinous Appendiceal Cancers: from Appendectomy to HIPEC.
The webinar was co-hosted by ACPMP Research Foundation and Minnesota’s Patient Advisory Council members, Meghan Blomquist and Angel Harrington who lead the MN Appendix Cancer Allies. This event was held via Zoom on October 27, 2021 and was free and open to all.